project id: TCGA-PRAD; case submitter id: TCGA-ZG-A9LZ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.59; rna integrity number: 8.7; age at index: 66; days to birth: -24132; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1945; age at diagnosis: 24132; ajcc clinical m: M0; ajcc clinical t: T3a; ajcc pathologic n: N0; ajcc pathologic t: T3b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 692.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 817; initial weight: 170.0; sample id: d4d800a3-2f29-456e-b4ea-c3cf307c1fce; sample submitter id: TCGA-ZG-A9LZ-01A; portion id: 65c98688-81ad-44f9-a310-8bf258296d06; portion submitter id: TCGA-ZG-A9LZ-01A-11; slide id: 3a6a9a84-5007-4b87-b13c-de98feb23631; slide submitter id: TCGA-ZG-A9LZ-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0; section location: TOP;